Advancing Alzheimer's Disease research through a preclinical model of SERPINA3
National Institute on AgingDescription
Alzheimer’s disease (AD) is the most prevalent age-related neurodegenerative disorder and a leading cause of dementia, with no available cure or disease-modifying therapy. Pathologically, AD is characterized by amyloid beta (Aβ) deposition, neuronal loss, synaptic dysfunction, and glial cell-mediated neuroinflammation. Among inflammatory mediators, SERPINA3, a serine protease inhibitor, has been implicated in AD pathogenesis. SERPINA3 is a major component of amyloid plaques, and its overexpression in glial cells exacerbates AD-like pathology in transgenic mouse models. However, its precise role in disease progression remains poorly understood. To investigate the role of SERPINA3 in AD, we generated a Serpina3-deficient mouse model (Serpina3LD/LD). While the human genome encodes a single SERPINA3 gene, the mouse genome contains a cluster of 14 orthologs. Our model was engineered to delete all 14 Serpina3 genes, enabling a more accurate assessment of SERPINA3 function in disease. Crossing Serpina3 LD/LD mice with the 5XFAD amyloidogenic model resulted in a striking 50 - 60% reduction in plaque burden within the brain of these animals, highlighting SERPINA3 as a key mediator of AD pathogenesis and a promising therapeutic target. While ongoing studies aiming to elucidate the mechanisms underlying this phenotype are under way, here we seek to accelerate translational research by developing and validating a humanized SERPINA3 mouse model in the context of AD. This model will facilitate in vivo testing of SERPINA3-targeted therapeutics, advancing the development of novel treatments for AD. Project Number: 1R21AG098408-01 | Fiscal Year: 2026 | NIH Institute/Center: National Institute on Aging (NIA) | Principal Investigator: Stephane Pelletier | Institution: INDIANA UNIVERSITY INDIANAPOLIS, INDIANAPOLIS, IN | Award Amount: $435,875 | Activity Code: R21 | Study Section: Chronic Dysfunction and Integrative Neurodegeneration Study Section[CDIN] View on NIH RePORTER: https://reporter.nih.gov/project-details/11287272
Interested in this grant?
Start a free 7-day trial to get match scores, save grants, and build your application with AI.
Grant Details
$435,875 - $435,875
Not specified
INDIANAPOLIS, IN
View the application link
Start a free 7-day trial to open the original listing and funder website, save this grant, and track its deadline. Cancel anytime.
Start free trialWant to see how well this grant matches your organization?
Get Your Match Score